1. Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study 
Vasilios Papademetriou, MD, DSc, Eric S. Nylen, MD, Michael Doumas, MD, Jeff Probstfield, MD, Johannes F.E. Mann, MD, Richard E. Gilbert, MD, Hertzel C. Gerstein, MD, MSc 
The American Journal of Medicine 
Volume 130, Issue 12, Pages 1465.e e39 (December 2017)
DOI: /j.amjmed
Copyright © Terms and Conditions

2. Figure 1
(A) Rates and hazard ratios (HRs) of primary and secondary outcomes in patients with and without chronic kidney disease (CKD), adjusted for treatment allocation, glycemic status, and prior cardiovascular event. (B) HRs for the primary outcome for patients with and without CKD in all prespecified subgroups, adjusted for treatment allocation, glycemic status, and prior cardiovascular event. CV = cardiovascular; DCCT = Diabetes Control + Complications Trial; HF = heart failure; MI = myocardial infarction.
The American Journal of Medicine  , 1465.e e39DOI: ( /j.amjmed )
Copyright © Terms and Conditions

3. Figure 2
(A) Kaplan-Meier curves for the primary outcome among participants without chronic kidney disease (CKD), CKD stage 1 and 2, and CKD stage 3. (B) Kaplan-Meier curves for all-cause mortality among participants without CKD, CKD stage 1 and 2, and CKD stage 3. (C) Kaplan-Meier curves for cardiovascular mortality among participants without CKD, CKD stage 1 and 2, and CKD stage 3.
The American Journal of Medicine  , 1465.e e39DOI: ( /j.amjmed )
Copyright © Terms and Conditions

4. Supplementary Figure
(A) Rates and hazard ratios (HRs) (95% confidence intereval [CI]) of primary and secondary outcome in patients with and without chronic kidney disease (CKD) adjusted for albuminuria, treatment allocation, glycemic status, and prior cardiovascular event. (B) HRs for primary outcome for all prespecified subgroups of patients with and without CKD adjusted for albuminuria, treatment allocation, glycemic status, and prior cardiovascular event.
The American Journal of Medicine  , 1465.e e39DOI: ( /j.amjmed )
Copyright © Terms and Conditions